Oncotarget

Meta-Analysis:

Legume intake and risk of prostate cancer: a meta-analysis of prospective cohort studies

PDF |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:44776-44784. https://doi.org/10.18632/oncotarget.16794

Metrics: PDF 1683 views  |   HTML 1734 views  |   ?  

Jie Li _ and Qi-Qi Mao

Abstract

Jie Li1 and Qi-Qi Mao2

1Department of Urology, Lishui Central Hospital, The Fifth Affiliated Hospital, Wenzhou Medical University, Lishui, 323000, Zhejiang, China

2Department of Urology, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, 310003, Zhejiang, China

Correspondence to:

Jie Li, email: lishuilijie2011@sina.com

Keywords: legume, prostatic neoplasm, meta-analysis, epidemiology

Received: February 21, 2017     Accepted: March 21, 2017     Published: April 03, 2017

ABSTRACT

Previous studies regarding the relationship between legume intake and risk of prostate cancer have reported inconsistent results. We conducted a meta-analysis of prospective cohort studies to summarize evidence on this association. A systematic literature search of articles published through June 2016 was performed using PubMed and Web of Science databases. The combined relative risk (RR) with its 95% confidence interval (CI) for the highest versus the lowest intake of legumes was calculated with a random-effects model. Dose-response meta-analysis was also performed for the studies that provided at least three levels of legume consumption. Ten articles (eight cohorts) reporting 281,034 individuals and 10,234 incident cases were identified. The individuals with high consumption of legumes compared with the reference group experienced a significantly reduced risk for developing prostate cancer (RR: 0.85 [95% CI 0.75−0.96], P = 0.010). Moderate heterogeneity of RRs was observed across these studies (P = 0.064 for heterogeneity, I2 = 45.8 %). Dose-response meta-analysis indicated that the risk of prostate cancer reduced by 3.7% (95% CI 1.5%−5.8%) for each 20 grams per day increment of legume intake. In conclusion, the results from this meta-analysis suggest that a high intake of legumes is associated with a low incidence of prostate cancer.


INTRODUCTION

Prostate cancer is the second most common cancer in men worldwide, with 1,111,700 newly diagnosed cases and 307,500 deaths estimated to have occurred in 2012 [1]. Age, race/ethnicity, and family history of prostate cancer are the most established risk factors for prostate cancer [2]. Several modifiable factors, such as physical activity [3] and intake of specified vegetables (e.g., carrots [4] and cruciferous vegetables [5]), also have been reported to be associated with prostate cancer incidence, although controversies still persist.

Legumes contain a broad class of bioactive compounds for which anti-carcinogenic roles have been indicated by experimental studies, either directly or through further metabolizing by gut microbiota [6]. In epidemiological studies, legume intake has been linked with a reduced risk of colorectal adenoma [7] and colorectal cancer [8]. Several prospective cohort studies also have investigated whether consumption of legumes is a potential protective factor for prostate cancer with inconsistent results. Diallo et al. [9] and Schuurman et al. [10] reported an inverse association between risk of prostate cancer and legume intake. In contrast, Kirsh et al. [11] found no significant risk reduction associated with consumption of legumes. Hence, this association warrants further investigation.

With the aim of exploring the risk of prostate cancer at different levels of legume consumption, we performed a meta-analysis of prospective cohort studies published up to June 2016.

RESULTS

Study selection

With the search strategy, 840 unique publications were initially retrieved. After reading the titles and abstracts, 47 articles were considered of interest and full text was retrieved for further evaluation. Thirty-seven of these 47 articles were subsequently excluded and finally 10 articles [918] were included in the current meta-analysis (Figure 1).

Process of study selection.

Figure 1: Process of study selection.

Study characteristics

Two included articles published by Park et al. (2008 [18] and 2015 [17]) used the same cohort (Multiethnic Cohort Study). In this meta-analysis, the later study [17] was included in overall analysis as it had a longer follow-up, while the earlier study [18] was adopted in dose-response analysis and subgroup analysis as it provided person-years in each exposure category and RRs for various types of legumes. Similarly, a study performed by Jacobsen et al. [13] was only included in subgroup analysis as it had duplicate population with Mills et al. [15] and only reported one type of legumes. Therefore, a total of eight cohorts reporting 281,034 individuals and 10,234 incident cases were identified. Four cohorts were based in North America, two in Europe, and two in Asia. No studies were based in Africa, Oceania, or South America. Articles were published between August 1989 and March 2016. All of ten articles were prospective cohort studies.

The methodological quality of the included articles was generally good (mean score of NOS = 6.7). All studies had described independent, consecutive sampling of their cohort. Mean or median follow-up duration ranged from 4.2 to 19.4 years. Participants were followed up for an average of over 7 years in the most of articles (70.0%). The sample sizes of the cohorts ranged from 3,313 to 82,483, with the four largest studies recruiting individuals over 40 thousand (Table 1).

Table 1: Summary characteristics of the studies included in this meta-analysis

Abbreviations: No., number; FFQ, food frequency questionnaire; PSA, prostate-specific antigen; NOS, Newcastle-Ottawa Scale; y, year; BMI, body mass index; SU.VI.MAX, Supplémentation en Vitamines et Minéraux Antioxydants; MCS, Multiethnic Cohort Study; JPHC-BPS, Japan Public Health Center-Based Prospective Study; PLCO, Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial; LSS, Life Span Study; J-HCS, Japan-Hawaii Cancer Study; NCS, Netherlands Cohort Study; AHS, Adventist Health Study.

Of all the articles, six investigated the whole legume foods, two studied total soy foods, one investigated tofu, and one focused on soy milk. The ascertainment of prostate cancer based on cancer registries (seven studies), histologically examination (two studies), or medical and pathology records (one studies) (Table 1).

Adjusted RRs could be determined for all cohort studies. Each risk estimate was adjusted for age. Five studies (50.0%) reported an estimate adjusted for at least one of the other two established risk factors for prostate cancer: race (3 cohorts) and family history of prostate cancer (5 cohorts). Four articles provided estimates adjusted for total energy intake. Detailed information on adjustments is present in Table 1.

Overall analysis

Figure 2 showed the results from the random effects model combining the RRs for prostate cancer. Overall, the individuals with high consumption of legumes compared with the reference group experienced a significantly reduced risk for developing prostate cancer (RR: 0.85 [95% CI 0.75–0.96], P = 0.010). Moderate heterogeneity of RRs was observed across these studies (P = 0.064 for heterogeneity, I2 = 45.8 %). Therefore, we explored the potential sources (i.e., geographic area, follow-up time, publication year, and sample size) of heterogeneity by using meta-regression. As a result, only the sample size (P = 0.033) was identified as a possible source of heterogeneity in the overall meta-analysis. In addition, we also used Galbraith plot to detect studies that might contribute to heterogeneity. As a result, we found that the Diallo et al.’ study [9] was the major source of heterogeneity (Supplementary Figure 1). After excluding this study, there was no significant heterogeneity (P = 0.232, I2 = 24.7%), and the combined RR (95% CI) was 0.90 (0.81–0.99).

A forest plot showing risk estimates from cohort studies estimating the association between overall legume consumption and risk of prostate cancer.

Figure 2: A forest plot showing risk estimates from cohort studies estimating the association between overall legume consumption and risk of prostate cancer.

Considering three studies only reported risk estimates for total soy food or one type of soy food, in order to allow an unbiased comparison, we also computed the RR for whole legume foods from the remaining five studies. Compared with subject with low intake of legumes, the individuals with high consumption of whole legumes experienced a significant reduced risk for developing prostate cancer (RR: 0.85 [95% CI 0.72–0.99], P = 0.041). Funnel plot (Supplementary Figure 2), Egger’s and Begg’s tests all showed evidence of publication bias (Egger, P = 0.016; Begg, P = 0.022).

Stratified analyses

Next, we performed stratified analyses based on a number of key study characteristics (Table 2). We firstly carried out stratified analysis according to geographical region, significant protective effect of legumes intake against prostate cancer was observed in European populations (RR 0.64, 95% CI 0.49–0.84, P = 0.001), but not in other geographical populations. When stratified by type of legumes, the analysis limited to soy products yielded an RR of 0.89 (95% CI 0.78–1.01, P = 0.069). In the subgroup analysis by follow-up time, the RRs (95% CI) were 0.80 (0.64–1.02) and 0.86 (0.71–1.03) for follow-up > 10 years and ≤ 10 years, respectively. Finally, in the stratified analyses by sample size and publication year, statistically significant association was observed in those small studies (RR 0.68, 95 % CI 0.54–0.85, P = 0.001) and studies published before 2005 (RR 0.72, 95 % CI 0.59–0.88, P = 0.002).

Table 2: Stratified analysis of the association between legume intake and risk of prostate cancer

Subgroup

Included studies

Pooled RR (95% CI)

P

Heterogeneity

Q

I2 (%)

P

Total

8

0.85 (0.75–0.96)

0.010

14.75

45.8

0.064

Geographical region

 Europe

2

0.64 (0.49–0.84)

0.001

1.04

3.6

0.308

 North America

4

0.93 (0.84–1.04)

0.213

5.57

28.2

0.233

 Asia

2

0.81 (0.62–1.06)

0.119

0.02

0.0

0.893

Type of legumes

 Whole legumes

5

0.85 (0.72–0.99)

0.041

13.63

63.3

0.018

 Soy products

5

0.89 (0.78–1.01)

0.069

5.07

21.1

0.280

 Legumes excluding soy products

2

0.93 (0.84–1.03)

0.156

1.09

8.0

0.297

Follow-up time

 > 10 years

4

0.80 (0.64–1.02)

0.067

6.63

54.7

0.085

 ≤ 10 years

4

0.86 (0.71–1.03)

0.099

8.11

50.7

0.087

Sample size

 > 20,000

4

0.94 (0.87–1.01)

0.075

4.07

1.6

0.397

 ≤ 20,000

4

0.68 (0.54–0.85)

0.001

3.31

9.4

0.346

Publication year

 > 2005

4

0.92 (0.81–1.04)

0.177

7.24

44.7

0.124

 ≤ 2005

4

0.72 (0.59–0.88)

0.002

1.86

0.0

0.601

Abbreviations: RR, relative risk; CI, confidence interval.

Sensitivity analysis and cumulative meta-analysis

The influence of each included study on the pooled risk estimate was assessed by repeating the meta-analysis after omitting each study in turn. The results suggested that the combined RR was not dominated by any single study. The RRs ranged from a low of 0.81 (95% CI 0.69–0.95) to a high of 0.90 (95% CI 0.81–0.99) via omission of the study by Park et al. [17] and the study by Diallo et al. [9], respectively (Figure 3).

Sensitivity analysis was performed by removing each study in turn and recalculating the pooled relative risk estimates.

Figure 3: Sensitivity analysis was performed by removing each study in turn and recalculating the pooled relative risk estimates.

Cumulative meta-analysis is the process of repeated meta-analysis of individual studies each time adding a new study. In this study, we performed the cumulative meta-analysis according to publication year. As shown in Supplementary Figure 3, The 95% CIs gradually became narrower with increasing sample size, suggesting that the precision of the pooled RRs was progressively boosted by the continual addition of more studies.

Dose-response relationship and incidence of prostate cancer

After evaluating dose-response patterns for intake of legumes per day, we observed a linear decrease in prostate cancer risk with increasing legumes consumption (P = 0.41 for non-linearity). The risk reduced by 3.7% (95% CI 1.5%–5.8%) for every additional 20 grams per day (for example, an individual who intakes 100 grams legumes per day has a relative reduced risk of 17.2% [95% CI 7.3%–25.8%] for developing prostate cancer compared with someone who never consumes legumes) (Figure 4).

Linear dose-response relationship between relative risk (RR) of prostate cancer and legume consumption.

Figure 4: Linear dose-response relationship between relative risk (RR) of prostate cancer and legume consumption. Solid line represents the estimated RRs and the dotted lines represent the 95% confidence intervals (CIs). Circles present the dose-specific RRs reported in each study. The area of each circle is proportional to the inverse variance of the RR.

From four population-based studies that reported information on person-years in the highest and lowest categories of legume intake, we could calculate absolute annual rates of prostate cancer cases from the general population: 176.3 cases per 100,000 person-years in the highest group and 152.0 cases in the lowest group.

DISCUSSION

The current meta-analysis involved approximately 280 thousand participants and 10 thousand patients with prostate cancer from eight prospective cohort studies. To the best of our knowledge, this is the first meta-analysis evaluating the relationship between legume intake and risk of prostate cancer. The results indicated that high level of legume consumption was inversely associated with the incidence of prostate cancer. A dose-response relationship was also observed. The risk of prostate cancer reduced by 3.7% (95% CI 1.5%–5.8%) for each 20 grams per day increment of legume intake.

Two meta-analysis published in 2009 [19, 20] investigated the relationship between soy food consumption and risk of prostate cancer and observed that intake of soy foods was associated with a reduction in risk of prostate cancer. However, these studies included both cohort and case-control studies. When they restricted the analysis to cohort studies in subgroup analysis, the association became weaker. Similarly, in our study we also only observed a borderline association between soy intake and prostate cancer risk in stratified analysis, which was likely due to the small number of eligible studies (n = 5) and, hence, insufficient statistical power. However, these results also implied that other types of legumes except soybeans might contribute the protective effects of whole legumes on incidence of prostate cancer, which is worthy of further investigation in future studies.

Heterogeneity is often a concern in a meta-analysis. Moderate heterogeneity was observed among included studies, which could distort the pooled risk estimates. Heterogeneity is caused by variation in definitions and ranges of legume intake, methods of exposure and outcome assessment, and sources of study population. According to the results of meta-regression analysis, we think the difference in sample size is the major source of between-study heterogeneity. In addition, we removed the studies that obviously contributed to the heterogeneity through the Galbraith plot and then repeated the meta-analysis. The relationship still persisted without any significant heterogeneity. These results indicated our findings were robust and less likely affected by the heterogeneity.

A causal relationship between legume intake and prostate cancer risk may be mediated by several mechanisms because of a great variety of anti-carcinogens in legumes. Flavonoids, especially isoflavones, may be the most important contributor to the anti-cancer activity of legumes. Mukhtar et al. reported that dietary flavonoid fisetin could inhibit proliferation, migration, and invasion by binding to β-tubulin and disrupting microtubule dynamics in prostate cancer cells [21]. It also has been demonstrated that isoflavone can inhibit prostate carcinogenesis in the rat [22]. Furthermore, isoflavones sensitize cancer cells to radiotherapy through altered activation of APE1/Ref-1, NF-κB, and HIF-1α [23, 24]. Dietary fiber is another major component of legumes and probably plays a crucial role in this observed association. Dietary fiber may reduce concentrations of circulating androgens through increasing sex hormone-binding globulin concentration [25]. Low circulating levels of testosterone have been indicated to be associated with a reduced risk of prostate cancer [26].

Strengths of our meta-analysis include the strict inclusion criteria, especially restriction to prospective cohort studies, which greatly reduced the likelihood of recall and selection biases. In addition, as individual studies had limited statistical power, our study expanded the sample size and provided more reliable estimates. Finally, the reliability of the findings in sensitivity analyses and Galbraith plot analysis, as well as the significant dose-response relationship, further strengthened our findings.

A potential limitation of this study is the inadequate control of all known confounding factors in included studies, which may bias the results in either direction, toward exaggeration or underestimation of the effect size estimates [27]. Another limitation is the existence of publication bias suggested by Begg’s and Egger’ tests. Although we used loose search criteria, gray literature, due to its diverse origins and unpublished nature, may be difficult to find. Small negative studies are also less likely to be published. In addition, like all meta-analyses, our study has the limitation of being a retrospective analysis. Finally, various cut-off points for the categories of legume intake were used in the included studies, which might lead to the heterogeneity and affect the pooled risk estimate.

In conclusion, the results from this meta-analysis suggest that a high intake of legumes is associated with a low incidence of prostate cancer. Considering the limited included studies, further large well-designed cohort studies are warranted to confirm the findings from this meta-analysis. In addition, the mechanisms and active compounds in legumes mediated this relationship remain to be elucidated.

MATERIALS AND METHODS

Search strategy

This meta-analysis follows the standards of quality for reporting meta-analyses [28]. We searched the publications recorded in the electronic databases PubMed and Web of Science using the following text and key words in combination both as MeSH terms and text-word form (“legume” or “pulse” or “soy” or “beans” or “lentils” or “peas” or “soybeans” or “tofu” or “soymilk” or “vegetable” or “nutrition” or “diet”) and (“prostatic neoplasms” or “prostatic cancer” or “prostate neoplasms” or “prostate cancer”) and (“prospective” or “cohort” or “nested case-control”). We searched studies published in any language and checked references from these studies to identify other relevant studies.

Study selection

To reduce varieties between studies, we adopted the following methodological restrictions as the inclusion criteria: studies that provided the minimum information essential to calculate the relative risk (RR) associated with intake of legumes, including cohort and nested case-control studies published as original articles. In instances of duplicate publications, the most comprehensive information with the longest follow-up was used.

Data abstraction

Articles were reviewed and cross-checked independently by two investigators (J.L. and Q.Q.M). Data on the following characteristics were collected: surname of the first author, publication year, study design, study population, sample size, number of patients who developed prostate cancer, mean or median years of follow-up, study location (defined as Europe, North America, or Asia), type of legumes studied, assessment of exposure, ascertainment of prostate cancer, and reported adjustment for potential confounding factors. When available, we used the effect size estimates from the most fully adjusted model. Any disagreements were resolved by consensus.

Quality assessment

The quality of each study was evaluated by the same two investigators using the Newcastle-Ottawa Scale (NOS, http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp). This scale is an eight-item instrument designed to assess study population and selection, study comparability, follow-up, and assessment of outcome. One or two points were awarded for each criterion and then points were added up to compare study quality in a quantitative manner. We assigned total points of < 7 and ≥ 7 for low and high quality of studies, respectively.

Data analysis

Pooled RR and its 95% confidence interval (CI) was calculated by combining the study specific estimates with a random-effects model [29] that accounted for between-study heterogeneity, as significant heterogeneity was anticipated among studies. We calculated the Cochran’s Q (the level of significance was set at 0.1) and I2 statistic [30] to evaluate the heterogeneity across studies, applying the following interpretation for I2 < 25%, low heterogeneity; 25%–50%, moderate heterogeneity; > 50%, large or extreme heterogeneity. Various sensitivity analyses, stratified analyses and meta-regression models were performed to explore the potential sources of between-study heterogeneity. In addition to those, the Galbraith plot [31] was used to detect studies that contributed to heterogeneity and re-analysis was performed when the studies possibly leading to the heterogeneity were excluded. Cumulative meta-analysis was also performed through assortment of studies with publication date.

In the dose-response analysis, we included studies that provided at least three levels of legume consumption and person-years in each exposure category. Because most included studies provided categorical data with a range for exposures, we assigned the mid-point in each category to the corresponding RR for each study. When the highest category was open ended, we assumed the width of the interval to be the same as in the preceding category. We used generalized least squares trend (GLST) regression model [32, 33] to assess the pooled dose-response relation between intake of legumes and risk of prostate cancer across studies that had heterogeneous categorizations of legume intake. In addition, we examined a potential nonlinear dose-response relationship by modeling legume intake using restricted cubic splines with three knots at percentiles 25%, 50%, and 75% of the distribution [34]. A P value for nonlinearity was calculated by testing the null hypothesis that the coefficient of the second spline is equal to 0.

To calculate the person-years in each exposure category, we extracted data from articles that specified one or more of the following: total person-years of follow-up; sample size and mean (or median) follow-up time; or sample size and cumulative incidence rate. Event rates were expressed as per 100,000 patient-years at risk. Weighted meta-analytic prevalence estimates for outcome were calculated with an inverse-variance random-effects model. The variance was stabilized using the Freeman-Tukey type arcsine square-root transformation [35].

Small study bias (i.e., publication bias) was assessed with funnel plot, Begg’s test (rank correlation method) [36] and Egger’s test (linear regression method) [37]. All of the statistical analyses were performed with STATA 11.0 (StataCorp, College Station, TX, USA). Statistical tests were two sided and imposed a significance level of P < 0.05.

ACKNOWLEDGMENTS AND FUNDING

The authors have no support or funding to this report.

CONFLICTS OF INTEREST

The authors declare no conflicts of interest.

REFERENCES

1. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015; 65:87–108.

2. Attard G, Parker C, Eeles RA, Schroder F, Tomlins SA, Tannock I, Drake CG and de Bono JS. Prostate cancer. Lancet. 2016; 387:70–82.

3. Liu Y, Hu F, Li D, Wang F, Zhu L, Chen W, Ge J, An R, Zhao Y. Does physical activity reduce the risk of prostate cancer? A systematic review and meta-analysis. Eur Urol. 2011; 60:1029–1044.

4. Xu X, Cheng Y, Li S, Zhu Y, Zheng X, Mao Q, Xie L. Dietary carrot consumption and the risk of prostate cancer. Eur J Nutr. 2014; 53:1615–1623.

5. Liu B, Mao Q, Cao M, Xie L. Cruciferous vegetables intake and risk of prostate cancer: a meta-analysis. Int J Urol. 2012; 19:134–141.

6. Sanchez-Chino X, Jimenez-Martinez C, Davila-Ortiz G, Alvarez-Gonzalez I, Madrigal-Bujaidar E. Nutrient and nonnutrient components of legumes, and its chemopreventive activity: a review. Nutr Cancer. 2015; 67:401–410.

7. Wang Y, Wang Z, Fu L, Chen Y, Fang J. Legume consumption and colorectal adenoma risk: a meta-analysis of observational studies. PLoS One. 2013; 8:e67335.

8. Zhu B, Sun Y, Qi L, Zhong R, Miao X. Dietary legume consumption reduces risk of colorectal cancer: evidence from a meta-analysis of cohort studies. Sci Rep. 2015; 5:8797.

9. Diallo A, Deschasaux M, Galan P, Hercberg S, Zelek L, Latino-Martel P, Touvier M. Associations between fruit, vegetable and legume intakes and prostate cancer risk: results from the prospective Supplementation en Vitamines et Mineraux Antioxydants (SU.VI.MAX) cohort. Br J Nutr. 2016; 115:1579–1585.

10. Schuurman AG, Goldbohm RA, Dorant E and van den Brandt PA. Vegetable and fruit consumption and prostate cancer risk: a cohort study in The Netherlands. Cancer Epidemiol Biomarkers Prev. 1998; 7:673–680.

11. Kirsh VA, Peters U, Mayne ST, Subar AF, Chatterjee N, Johnson CC, Hayes RB. Prospective study of fruit and vegetable intake and risk of prostate cancer. J Natl Cancer Inst. 2007; 99:1200–1209.

12. Allen NE, Sauvaget C, Roddam AW, Appleby P, Nagano J, Suzuki G, Key TJ, Koyama K. A prospective study of diet and prostate cancer in Japanese men. Cancer Causes Control. 2004; 15:911–920.

13. Jacobsen BK, Knutsen SF, Fraser GE. Does high soy milk intake reduce prostate cancer incidence? The Adventist Health Study (United States). Cancer Causes Control. 1998; 9:553–557.

14. Kurahashi N, Iwasaki M, Sasazuki S, Otani T, Inoue M, Tsugane S. Soy product and isoflavone consumption in relation to prostate cancer in Japanese men. Cancer Epidemiol Biomarkers Prev. 2007; 16:538–545.

15. Mills PK, Beeson WL, Phillips RL, Fraser GE. Cohort study of diet, lifestyle, and prostate cancer in Adventist men. Cancer. 1989; 64:598–604.

16. Nomura AM, Hankin JH, Lee J, Stemmermann GN. Cohort study of tofu intake and prostate cancer: no apparent association. Cancer Epidemiol Biomarkers Prev. 2004; 13:2277–2279.

17. Park SY, Haiman CA, Cheng I, Park SL, Wilkens LR, Kolonel LN, Le Marchand L, Henderson BE. Racial/ethnic differences in lifestyle-related factors and prostate cancer risk: the Multiethnic Cohort Study. Cancer Causes Control. 2015; 26:1507–1515.

18. Park SY, Murphy SP, Wilkens LR, Henderson BE, Kolonel LN. Legume and isoflavone intake and prostate cancer risk: The Multiethnic Cohort Study. Int J Cancer. 2008; 123:927–932.

19. Yan L, Spitznagel EL. Soy consumption and prostate cancer risk in men: a revisit of a meta-analysis. Am J Clin Nutr. 2009; 89:1155–1163.

20. Hwang YW, Kim SY, Jee SH, Kim YN, Nam CM. Soy food consumption and risk of prostate cancer: a meta-analysis of observational studies. Nutr Cancer. 2009; 61:598–606.

21. Mukhtar E, Adhami VM, Sechi M, Mukhtar H. Dietary flavonoid fisetin binds to beta-tubulin and disrupts microtubule dynamics in prostate cancer cells. Cancer Lett. 2015; 367:173–183.

22. McCormick DL, Johnson WD, Bosland MC, Lubet RA, Steele VE. Chemoprevention of rat prostate carcinogenesis by soy isoflavones and by Bowman-Birk inhibitor. Nutr Cancer. 2007; 57:184–193.

23. Hillman GG, Singh-Gupta V. Soy isoflavones sensitize cancer cells to radiotherapy. Free Radic Biol Med. 2011; 51:289–298.

24. Raffoul JJ, Sarkar FH, Hillman GG. Radiosensitization of prostate cancer by soy isoflavones. Curr Cancer Drug Targets. 2007; 7:759–765.

25. Longcope C, Feldman HA, McKinlay JB, Araujo AB. Diet and sex hormone-binding globulin. J Clin Endocrinol Metab. 2000; 85:293–296.

26. Hyde Z, Flicker L, McCaul KA, Almeida OP, Hankey GJ, Chubb SA, Yeap BB. Associations between testosterone levels and incident prostate, lung, and colorectal cancer. A population-based study. Cancer Epidemiol Biomarkers Prev. 2012; 21:1319–1329.

27. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA. 2010; 303:1077–1083.

28. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009; 6:e1000097.

29. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986; 7:177–188.

30. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539–1558.

31. Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, Moons KG. More than numbers: the power of graphs in meta-analysis. Am J Epidemiol. 2009; 169:249–255.

32. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992; 135:1301–1309.

33. Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012; 175:66–73.

34. Harrell FE Jr, Lee KL, Pollock BG. Regression models in clinical studies: determining relationships between predictors and response. J Natl Cancer Inst. 1988; 80:1198–1202.

35. Nyaga VN, Arbyn M, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014; 72:39.

36. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994; 50:1088–1101.

37. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315:629–634.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 16794